JavaScript is required

Medicinal Cannabis and Safe Driving Closed Circuit Track Trial

The Victorian Government is running a world-first trial to evaluate the effects of THC prescribed medicinal cannabis on the driving performance of patients within a controlled-track environment.

Why are we running the trial?

Medicinal cannabis is increasingly used for its potential therapeutic benefits. Medicinal cannabis products typically contain varying concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

There is limited evidence about the impact of prescribed THC-containing medicinal cannabis on real-world driver performance.

Currently, it is illegal in Victoria to drive with any detectable amount of THC, the active compound in medicinal cannabis –which can remain in a person’s system for several days after they take their prescribed medication.

While work has been undertaken to understand the impacts of THC on impairment, significant gaps exist in our understanding of the impacts of medicinal cannabis (containing THC) on driving performance.

Victoria is home to the first study of its kind in the world that will look at the impacts of patients prescribed medicinal cannabis driving in real-world conditions.

The outcomes of this study will add to the evidence-base and knowledge needed to determine if Victorians who are prescribed medicinal cannabis (containing THC) can be in control of a vehicle without compromising their safety, or the safety of other road users.

Medicinal Cannabis Track Trial

The medicinal cannabis track trial, being conducted by Swinburne University, will take place on a closed-circuit track mimicking real-world driving conditions.

Researchers will review participants’ ability to manage distractions and assess their driving performance including steering, braking and speed control.

Participants will be closely monitored throughout the trial and a number of process and protections will be in place to ensure the safety of participants and others at the track.

Trial participation

Trial participation is subject to strict eligibility criteria and participants will be compensated for their time. Participants need to meet the following criteria to be included in the study:

  1. have a valid and current medicinal cannabis prescription lasting more than six months for one of these conditions:
    • chronic pain,
    • mental health condition (such as anxiety or depression)
    • sleep disorder.
  2. be using medicinal cannabis for three months or longer, and on a stable dose (using the same amount each time on a regular schedule)
  3. be using a medicinal cannabis product that contains at least two milligrams of THC per dose.
  4. be 21 years of age or older.
  5. hold a current and unrestricted Victorian driver licence (no provisional or learner licence)
  6. be able to consume medicinal cannabis during the day as required for testing.

If you are interested in participating in the track trial, visit Swinburne University(opens in a new window) for more information, including the full eligibility criteria for participation.

Updated